Guidelines for the use of hydroxycarbamide in children and adults with sickle cell disease: A British Society for Haematology Guideline
- PMID: 29732531
- DOI: 10.1111/bjh.15235
Guidelines for the use of hydroxycarbamide in children and adults with sickle cell disease: A British Society for Haematology Guideline
Similar articles
-
Hydroxycarbamide treatment and brain MRI/MRA findings in children with sickle cell anaemia.Br J Haematol. 2016 Oct;175(2):331-338. doi: 10.1111/bjh.14235. Epub 2016 Sep 8. Br J Haematol. 2016. PMID: 27604981
-
Hydroxyurea information for children and parents.Paediatr Nurs. 2003 Mar;15(2):40-1. doi: 10.7748/paed.15.2.40.s21. Paediatr Nurs. 2003. PMID: 12677858 Review. No abstract available.
-
The effect of hydroxcarbamide therapy on survival of children with sickle cell disease.Br J Haematol. 2013 Jun;161(6):852-60. doi: 10.1111/bjh.12323. Epub 2013 Apr 17. Br J Haematol. 2013. PMID: 23590693 Clinical Trial.
-
Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia-TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial.Lancet. 2016 Feb 13;387(10019):661-670. doi: 10.1016/S0140-6736(15)01041-7. Epub 2015 Dec 6. Lancet. 2016. PMID: 26670617 Free PMC article. Clinical Trial.
-
The role of hydroxyurea in sickle cell disease.Br J Haematol. 2003 Jan;120(2):177-86. doi: 10.1046/j.1365-2141.2003.03849.x. Br J Haematol. 2003. PMID: 12542474 Review. No abstract available.
Cited by
-
KNOWLEDGE, ATTITUDE AND USE OF HYDROXUYREA AMONG ADULT SICKLE CELL DISEASE PATIENTS.Ann Ib Postgrad Med. 2019 Dec;17(2):153-156. Ann Ib Postgrad Med. 2019. PMID: 32669992 Free PMC article.
-
Transfusional Approach in Multi-Ethnic Sickle Cell Patients: Real-World Practice Data From a Multicenter Survey in Italy.Front Med (Lausanne). 2022 Mar 16;9:832154. doi: 10.3389/fmed.2022.832154. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35372393 Free PMC article.
-
Defining global strategies to improve outcomes in sickle cell disease: a Lancet Haematology Commission.Lancet Haematol. 2023 Aug;10(8):e633-e686. doi: 10.1016/S2352-3026(23)00096-0. Epub 2023 Jul 11. Lancet Haematol. 2023. PMID: 37451304 Free PMC article. Review.
-
Hydroxyurea to prevent brain injury in children with sickle cell disease (HU Prevent)-A randomized, placebo-controlled phase II feasibility/pilot study.Am J Hematol. 2024 Oct;99(10):1906-1916. doi: 10.1002/ajh.27423. Epub 2024 Jul 2. Am J Hematol. 2024. PMID: 38953438 Clinical Trial.
-
Sickle cell disease: an update.Clin Med (Lond). 2022 May;22(3):218-220. doi: 10.7861/clinmed.2022-0143. Clin Med (Lond). 2022. PMID: 35584832 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical